Trial Profile
A phase II trial of lenvatinib in patients with metastatic colorectal cancer after standard chemotherapy
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 22 Jan 2020
Price :
$35
*
At a glance
- Drugs Lenvatinib (Primary)
- Indications Adenocarcinoma; Colorectal cancer
- Focus Therapeutic Use
- Acronyms Lemon
- 29 Oct 2019 Status changed from active, no longer recruiting to completed.
- 04 Jun 2019 Results presented at the 55th Annual Meeting of the American Society of Clinical Oncology
- 19 Apr 2018 Status changed from recruiting to active, no longer recruiting.